Cytokinetics
CYTK
$65.34
Share price
0.83%
Change (1 day)
74.71%
Change (1 year)
Categories
Cytokinetics (CYTK) - Total debt
Total debt on the balance sheet as of December 2023 : $0.75 B
According to Cytokinetics 's latest financial reports the company's total debt is $0.75 B. A company’s total debt is the sum of all current and non-current debts.
Cytokinetics - Total debt on balance sheet (from 2003 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.75 B | 0.73% |
| 2022-12-31 | $0.75 B | 177.96% |
| 2021-12-31 | $0.26 B | 94.28% |
| 2020-12-31 | $0.13 B | 2.11% |
| 2019-12-31 | $0.13 B | 215.09% |
| 2018-12-31 | $43.18 M | 35.9% |
| 2017-12-31 | $31.77 M | 6.35% |
| 2016-12-31 | $29.88 M | 104.12% |
| 2015-12-31 | $14.63 M | |
| 2012-12-31 | $N/A | -100% |
| 2011-12-31 | $0.15 M | -84.57% |
| 2010-12-31 | $0.98 M | -92.31% |
| 2009-12-31 | $12.8 M | 175.91% |
| 2008-12-31 | $4.64 M | -46.6% |
| 2007-12-31 | $8.68 M | -19.81% |
| 2006-12-31 | $10.83 M | 15.73% |
| 2005-12-31 | $9.36 M | -10.78% |
| 2004-12-31 | $10.49 M | 4.07% |
| 2003-12-31 | $10.08 M | 6.23% |
| 2002-12-31 | $9.49 M | 169.28% |
| 2001-12-31 | $3.52 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $64.61 B | 8,449.28% | 🇺🇸 USA |
 Trevena TRVN | $35.31 M | -95.33% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $6.16 M | -99.18% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.19 B | -74.74% | 🇺🇸 USA |
 Array Technologies ARRY | $0.73 B | -3.35% | 🇺🇸 USA |